Telmisartan in Prostate Cancer

The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer, but evidence for treatment efficacy will also be gathered.

Trial Details

NCT ID
NCT06168487
Phase
PHASE1
Sponsor
Tyler J Curiel
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Telmisartan
  • Standard of Care Regimen
Locations (sample)
  • Lebanon, New Hampshire, United States|43.64229,-72.25176

Key Eligibility Criteria

  • Participants must be ≥18 years of age.
  • Participants must be able and willing to provide informed consent or have a surrogate capable of providing same.
  • Participants must not require immediate change in SOC treatment, i.e., patients with stable PSA (do not meet PCWG310 criteria for PSA progression),…
  • Participants must be receiving or likely to receive one of the following SOC agents for PC:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →